Boule Diagnostics shares hit historic low as cash runs out

Boule Diagnostics' stock plunged to an all-time low on the Stockholm exchange after reporting significantly weaker sales, depleting cash reserves. The decline pressures its largest shareholder, an investment company, and signals potential liquidity distress for the medtech firm.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works